Discontinuation report APO-TELMISARTAN/HCTZ
Report ID | 40826 |
Drug Identification Number | 02420023 |
Brand name | APO-TELMISARTAN/HCTZ |
Common or Proper name | TELMISARTAN/HCTZ |
Company Name | APOTEX INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
Strength(s) | 12.5MG 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-09-17 |
Actual discontinuation date | 2018-09-14 |
Remaining supply date | 2018-09-14 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-09-15 | English | Compare |
v4 | 2018-09-08 | French | Compare |
v3 | 2018-09-08 | English | Compare |
v2 | 2018-02-23 | French | Compare |
v1 | 2018-02-23 | English | Compare |
Showing 1 to 5 of 5